A surge in respiratory syncytial virus is hospitalizing more infants across the U.S., prompting health officials to urge vaccination for vulnerable groups to combat the infection.
- The current outbreak of respiratory syncytial virus is causing a rise in hospitalizations among infants, particularly during the onset of the fall-and-winter respiratory virus season.
- Health officials recommend a vaccine for high-risk groups, including pregnant women and seniors, to protect themselves and infants from severe infection and related complications.
- As respiratory syncytial virus spreads, there is heightened concern for infants developing bronchiolitis or pneumonia, conditions that can severely impact their respiratory system.
Why It Matters
The spike in respiratory syncytial virus cases underscores the importance of vaccination for vulnerable populations. Protecting these groups is crucial to safeguard infants and prevent overwhelming healthcare systems during peak respiratory virus seasons.